PET/CT技术用于肿瘤诊断的研究进展

被引：1

作者：

刘金烨 ^{[1
]}

李敏 ^{[2
]}

机构：

[1] 同济大学生命科学与技术学院

[2] 嘉定区中医医院肿瘤科

来源：

甘肃医药 | 2012年 / 31卷 / 10期

关键词：

PET/CT; 肿瘤检测; 示踪剂;

D O I：

10.15975/j.cnki.gsyy.2012.10.034

中图分类号：

R730.4 [肿瘤诊断学];

学科分类号：

100214 [肿瘤学];

摘要：

成像技术的发展使得与肿瘤相关的分子,生化和生理畸变过程的可视化成为可能。特别是采用PET/CT技术与放射性示踪剂相结合,可用于监测与人类癌症相关的细胞增殖,凋亡,肿瘤转移,血管新生等体内复杂的生物学过程,甚至研究与肿瘤相关的基因表达,受体与配体相互作用,底物运输和营养代谢等分子水平的事件。

引用

页码：743 / 748

页数：6

共 15 条

[1]

Positron Emission Tomography Imaging of Cancer Biology: Current Status and Future Prospects [J].

Chen, Kai ;

Chen, Xiaoyuan .

SEMINARS IN ONCOLOGY, 2011, 38 (01) :70-86

[2]

PET/CT in cancer research: from preclinical to clinical applications [J].

Del Vecchio, S. ;

Zannetti, A. ;

Fonti, R. ;

Iommelli, F. ;

Pizzuti, L. M. ;

Lettieri, A. ;

Salvatore, M. .

CONTRAST MEDIA & MOLECULAR IMAGING, 2010, 5 (04) :190-200

[3]

Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides [J].

Willmann, Juergen K. ;

Kimura, Richard H. ;

Deshpande, Nirupama ;

Lutz, Amelie M. ;

Cochran, Jennifer R. ;

Gambhir, Sanjiv S. .

JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (03) :433-440

[4]

Imaging matrix metalloproteinases in cancer [J].

Scherer, Randy L. ;

McIntyre, J. Oliver ;

Matrisian, Lynn M. .

CANCER AND METASTASIS REVIEWS, 2008, 27 (04) :679-690

[5]

Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET [J].

Reshef, Ayelet ;

Shirvan, Anat ;

Waterhouse, Rikki N. ;

Griniberg, Hagit ;

Levin, Galit ;

Cohen, Avi ;

Ulysse, Luckner G. ;

Friedman, Gad ;

Antoni, Gunnar ;

Zivi, Ilan .

JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (09) :1520-1528

[6]

Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis [J].

Zeng, Wenbin ;

Yao, Min-liang ;

Townsend, David ;

Kabalka, George ;

Wall, Jonathan ;

Le Puil, Michael ;

Biggerstaff, John ;

Miao, Weimin .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) :3573-3577

[7]

Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand ^sup 18^F-AH111585 in Breast Cancer Patients.[J].Kenny; Laura M;Coombes; R Charles;Oulie; Inger;Contractor; Kaiyumars B;Miller; Matthew;Spinks; Terence J;McParland; Brian;Cohen; Pamela S;Hui; Ai-Min;Palmieri; Carlo;Osman; Safiye;Glaser; Matthias;Turton; David;Al-Nahhas; Adil;Aboagye; Eric O.The Journal of Nuclear Medicine.2008, 6

[8]

Imaging of Cell Proliferation: Status and Prospects.[J].Bading; James R;Shields; Anthony F.The Journal of Nuclear Medicine.2008,

[9]

Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment [J].

Graf, Nicolas ;

Herrmann, Ken ;

den Hollander, Juergen ;

Fend, Falko ;

Schuster, Tibor ;

Wester, Hans-Juergen ;

Senekowitsch-Schmidtke, Reingard ;

zum Bueschenfelde, Christian Meyer ;

Peschel, Christian ;

Schwaiger, Markus ;

Dechow, Tobias ;

Buck, Andreas K. .

MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (06) :349-355

[10]

Comparison of 18F-FLT PET and 18F-FDG PET in Esophageal Cancer..van Westreenen H L;Cobben D C;Jager P L; et al;.J Nucl Med.2005, 03

← 1 2 →